FDA Committee Vote Boosts Peptide Market as Wellness Industry Eyes Deregulation
An FDA committee's vote to ease restrictions on key peptides could transform the wellness market, signaling a shift from the gray market to mainstream retail.
Archive
An FDA committee's vote to ease restrictions on key peptides could transform the wellness market, signaling a shift from the gray market to mainstream retail.